QAS International
QAS International is a Pakistan-based veterinary pharmaceutical manufacturer founded in 1990, producing 200+ WHO-GMP-compliant antibiotics, vaccines, dewormers, nutraceuticals, feed additives, and ectoparasiticides for poultry, livestock, and pigeon-fancier customers across 50+ cities.
- Company typePrivate
- Founded-
- HeadquartersGujranwala, Pakistan
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What QAS International does
QAS International is a privately held veterinary pharmaceutical company headquartered in Gujranwala, Punjab, Pakistan, operating under the trade name Quality Animal Solutions. Founded in 1990 and staffed by approximately 12 employees, the company manufactures and distributes a broad portfolio of more than 200 animal-health products under WHO-GMP guidelines, organized into six categories: poultry and livestock antibiotics, dewormers/anthelmintics, vaccines (including pigeon vaccines), nutraceuticals, feed additives, and ectoparasiticides. The catalog includes both generic-equivalent formulations (e.g., doxycycline, tilmicosin, albendazole, oxfendazole) and more differentiated products such as bacteriophage-based feed additives (XCELSIO) targeting Salmonella, E. coli, and Clostridium species as antibiotic-growth-promoter alternatives.
The company's go-to-market is sales-led and channels products primarily through a veterinary professional referral network, in which vets prescribe QAS products to commercial and small-scale poultry and livestock farmers across Pakistan. Distribution is reported to cover 50+ cities and 5,000+ clients nationwide, supplemented by a direct website storefront and visibility-building through major industry events (IPEX 2023-2025, DAE 2026). Customer segments are SMBs/individual farmers (poultry broiler/layer/breeder operations, dairy and beef cattle, buffalo, sheep, goat producers) plus a specialized pigeon-fancier niche served by the COLUMBA and PHARMAVAC vaccine lines.
Revenue mechanics are one-time product sales with no disclosed pricing, no subscription or recurring contract model, and no disclosed public funding, M&A, or institutional investment. The company appears founder/owner-operated with key team members including Ahmed Saleem Goriya, Syed Moeen Manzoor Shah, Hassan Ali Haider, Muhammad Ali Shahbaz, Dr. Shaista Tabassum, and Dr. Muhammad Bilal Afzal. There are no disclosed patents, trademarks, awards, or external partnerships, and operations are exclusively domestic within Pakistan with no global footprint claim.
QAS International firmographics
Firmographics- Name
- QAS International
- Legal name
- QAS International
- Website
- https://qasint.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- QAS International is a Pakistan-based veterinary pharmaceutical manufacturer founded in 1990, producing 200+ WHO-GMP-compliant antibiotics, vaccines, dewormers, nutraceuticals, feed additives, and ectoparasiticides for poultry, livestock, and pigeon-fancier customers across 50+ cities.
- Ownership category
- akta.pro rank
QAS International industry classification
Industry- Product category
- Veterinary Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)
- akta.pro secondary industries
- Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)
Keywords
Where QAS International is headquartered
LocationHeadquarters
- HQ city
- Gujranwala
- HQ country
- Pakistan
- HQ region
- Asia
Offices1 record
Markets served
QAS International business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Veterinary Pharmaceutical Product Sales: Sale of veterinary pharmaceuticals including antibiotics, vaccines, feed additives, nutraceuticals, dewormers, and NSAIDs to poultry and livestock farmers through veterinary professional channels.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
QAS International product offering
Product offeringCore offering
QAS International manufactures and distributes a comprehensive range of veterinary pharmaceuticals under WHO-GMP guidelines, including antibiotics, vaccines, feed additives, nutraceuticals, dewormers, and NSAIDs formulated for poultry and livestock. The company produces over 200 products and serves more than 5,000 clients across 50+ cities in Pakistan, primarily through veterinary professional networks.
Product overview
QAS International is a veterinary pharmaceutical company based in Pakistan offering a comprehensive range of pharmaceutical solutions for animal health. The product portfolio spans six main categories: (1) Antibiotics including broad-spectrum formulations like T.N ZONE-25, ENC ZONE-10, AMOXIQAS, DOXY ZONE products, and combination antibiotics such as DOX-T-ZONE, LEXOB, TAC ZONE, and TRI-BIT; (2) Dewormers/Anthelmintics including O.X ZONE, LEVOXY ZONE, WERMI ZONE, FENBENDA ZONE, DI-SC ZONE, and ANTI-ZONE; (3) Vaccines including COLUMBA, PHARMAVAC COLUMBI 2, PHARMAVAC PHA for pigeons, POLIOVIN clostridial vaccine, and GOAT POX VACCINE; (4) Nutraceuticals including vitamin supplements (C-QAS 20%, AD3ECKQAS, SELVIT-E, Super Multivit Extra, SUPER HYDROXY-D), liver tonics (HEPA QAS), electrolyte solutions (MENTAQAS.PLUS), metabolic energizers (DIANAGLYCOL), and probiotic formulations (BIORUM Probiotic); (5) Feed Additives including toxin binders (QASTOX PLATINUM), organic acids (PRO-FOCID, FORMPRO-ACID PH), bacteriophage preparations (XCELSIO), trace minerals (VASPRO-100), and live yeast probiotics (OPTIMIZE-10); (6) Ectoparasiticides including ECTO ZONE-98 and ECTO ZONE-100. All products are manufactured under WHO-GMP guidelines and are distributed throughout Pakistan serving over 5,000 clients across 50+ cities.
Differentiator
Problem solved
Functional benefit
Products and services
- T.N ZONE-25 Broad-spectrum oral antibiotic solution for poultry containing Tilmicosin Phosphate USP (250 mg/ml), formulated for prevention and treatment of respiratory infections caused by Tilmicosin-sensitive bacteria in broilers, layers, and breeders.
Companies that use QAS International
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
QAS International technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
QAS International partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Expansion highlights6 records
QAS International competitors and assessment
Company assessmentBroad incumbents
- Vetoquinol: Vetoquinol is a global animal health company with a portfolio of veterinary pharmaceuticals, vaccines, and nutraceuticals across livestock and companion animals. It sells in Pakistan and competes with QAS on antibiotics and specialty therapeutics, but with a broader global R&D and registration base.
- Huvepharma: Huvepharma is a global animal health and nutrition company offering pharmaceuticals, vaccines, enzymes, and feed additives for poultry and livestock. It sells in Pakistan and overlaps with QAS across most product categories, especially feed additives and antibiotics.
- Ceva Animal Health: Ceva is a global animal health company strong in poultry vaccines and pharmaceuticals with a significant presence in emerging markets. It competes with QAS in Pakistan's poultry segment, particularly on vaccines and respiratory/antibiotic treatments.
- Phibro Animal Health: Phibro Animal Health is a diversified global animal health and nutrition company with vaccines, antibiotics, and mineral/nutritional products for poultry and livestock. It competes with QAS in the Pakistan and broader emerging-market segments across multiple product categories.
- Elanco Animal Health: Elanco is a global animal health leader in livestock pharmaceuticals, vaccines, and parasiticides. It has a presence in Pakistan and competes with QAS across the poultry and livestock portfolio, especially on antibiotics and vaccines.
- Zoetis: Zoetis is the world's largest animal health company offering vaccines, antibiotics, parasiticides, and diagnostics for livestock and poultry. It is present in Pakistan and competes with QAS on premium products, but operates globally with vastly greater R&D and regulatory resources.
Regional players
- International Pharma Labs (IPL): IPL is a Pakistani manufacturer of animal health products including antibiotics and feed supplements. It is comparable to QAS on product type and Pakistani veterinary distribution but with a narrower portfolio and regional rather than nationwide focus.
Direct peers
- Star Laboratories (Pakistan): Star Laboratories is one of Pakistan's largest veterinary pharmaceutical manufacturers offering antibiotics, vaccines, feed additives, and nutraceuticals for poultry and livestock. It is the closest direct competitor to QAS in terms of product breadth, veterinary-channel distribution, and Pakistan market focus.
- Selmore Pharmaceuticals: Selmore Pharmaceuticals manufactures veterinary medicines (antibiotics, coccidiostats, vitamin-mineral premixes) for Pakistan's poultry and dairy sectors. Comparable to QAS on product mix, customer base, and distribution through veterinarians and farmers.
- Nawan Laboratories: Nawan Laboratories is a Pakistani veterinary pharmaceutical manufacturer producing antibiotics, anthelmintics, and nutritional supplements for poultry and livestock. It competes with QAS head-to-head in the same Pakistani veterinary professional channel and on similar generic molecules.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
QAS International social profiles
Digital presenceQAS International financial estimates
Financial estimateRevenue estimate
Valuation estimate
QAS International leadership team
Management profileNumber of profiles
Profiles6 records
QAS International funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
QAS International M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about QAS International
What does QAS International do?
QAS International manufactures and distributes a comprehensive range of veterinary pharmaceuticals under WHO-GMP guidelines, including antibiotics, vaccines, feed additives, nutraceuticals, dewormers, and NSAIDs formulated for poultry and livestock. The company produces over 200 products and serves more than 5,000 clients across 50+ cities in Pakistan, primarily through veterinary professional networks.
Is QAS International a public or private company?
QAS International is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was QAS International founded?
QAS International was founded in -1. It employs 11 to 50 people.
Where is QAS International based?
QAS International is headquartered in Gujranwala, Pakistan, in the Asia region.
How does QAS International make money?
One revenue line is on record: veterinary Pharmaceutical Product Sales.
Who are QAS International's main competitors?
Broad incumbents on record are Vetoquinol, Huvepharma, Ceva Animal Health, Phibro Animal Health, Elanco Animal Health and Zoetis. International Pharma Labs (IPL) is listed as a regional player. Direct peers are Star Laboratories (Pakistan), Selmore Pharmaceuticals and Nawan Laboratories.
Does QAS International have an API?
No public API is recorded for QAS International.
What industry is QAS International in?
QAS International's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAB, Livestock & Production Animal Therapeutics (Rx), with a secondary code of HLAMAIAA, Veterinary Pharmaceutical Wholesalers & Distributors. Its NAICS code is 325412 and its SIC code is 2834.